1
Hara Hideaki: (Ja) 露光装置及びデバイス製造方法, (En) Exposure apparatus and method for manufacturing device. Nikon Corporation, Hara Hideaki, SHIGA Masatake, October 21, 2004: WO/2004/090956 (166 worldwide citation)

(EN) An exposure apparatus (EX) is disclosed wherein an image of a pattern is projected onto a substrate (P) via a projection optical system (PL) and the substrate (P) is exposed to light. The exposure apparatus (EX) comprises a movable substrate stage (PST) for holding the substrate (P) above the p ...


2
Arai Dai, Hara Hideaki, Takaiwa Hiroaki: (Ja) 液体回収装置、露光装置、露光方法及びデバイス製造方法, (En) Liquid recovery apparatus, exposure apparatus, exposure method, and device production method. Nikon Corporation, Arai Dai, Hara Hideaki, Takaiwa Hiroaki, SHIGA Masatake, March 10, 2005: WO/2005/022615 (104 worldwide citation)

(EN) An exposure apparatus exposes a substrate by projecting an image of a pattern on the substrate by using a projection optical system and a liquid that fills a gap between the projection optical system and the substrate. The exposure apparatus has a liquid recovery mechanism with a drive section ...


3
Hara Hideaki, Takaiwa Hiroaki: (Ja) 露光装置及びデバイス製造方法, (En) Exposure apparatus and device producing method. Nikon Corporation, Hara Hideaki, Takaiwa Hiroaki, SHIGA Masatake, March 10, 2005: WO/2005/022616 (62 worldwide citation)

(EN) In an exposure apparatus (EX), a liquid (1) is placed between a projection optical system (PL) and a substrate (P), and the apparatus (EX) exposes the substrate (P) by projecting an image of a pattern on the substrate (P) through the optical projection system (PL) and the liquid (1). The appara ...


4
Hagihara Masahiko, Nishida Hiroshi, Tsuzaki Yasunori, Yoshimura Kimihiko, Komori Ken Ichi, Matsugi Takeshi, Nakajima Tadashi, Hatano Masakazu, Hara Hideaki: (Ja) 新規イソキノリン誘導体, (En) Novel isoquinoline derivative. Ube Industries, Santen Pharmaceutical, Hagihara Masahiko, Nishida Hiroshi, Tsuzaki Yasunori, Yoshimura Kimihiko, Komori Ken Ichi, Matsugi Takeshi, Nakajima Tadashi, Hatano Masakazu, Hara Hideaki, HIBI Norihiko, April 21, 2005: WO/2005/035503 (36 worldwide citation)

(EN) To prepare a novel isoquinoline derivative useful as a subject medicine and to find out a new pharmacological activity of the derivative. The compound is represented by the general formula [I] and has excellent Rho-kinase inhibitory activity. In the formula, X represents a benzene ring or monoc ...


5
Hagihara Masahiko, Komori Ken Ichi, Sunamoto Hidetoshi, Nishida Hiroshi, Matsugi Takeshi, Nakajima Tadashi, Hatano Masakazu, Kido Kazutaka, Hara Hideaki: (Ja) 新規インダゾール誘導体, (En) Novel indazole derivative. Ube Industries, Santen Pharmaceutical, Hagihara Masahiko, Komori Ken Ichi, Sunamoto Hidetoshi, Nishida Hiroshi, Matsugi Takeshi, Nakajima Tadashi, Hatano Masakazu, Kido Kazutaka, Hara Hideaki, HIBI Norihiko, April 21, 2005: WO/2005/035506 (23 worldwide citation)

(EN) To prepare a novel indazole derivative useful as a medicine and to find out a new pharmacological activity of the derivative. The compound is represented by the general formula [I] and has excellent Rho-kinase inhibitory activity. In the formula, ring X is a benzene ring or pyridine ring; R1 an ...


6
Hara Hideaki: (Ja) 露光装置及びデバイス製造方法, (En) Exposure apparatus and method for manufacturing device. Nikon Corporation, Hara Hideaki, SHIGA Masatake, October 6, 2005: WO/2005/093791 (18 worldwide citation)

(EN) Disclosed is an exposure apparatus which is capable of supplying and recovering a liquid in a desired state, thereby enabling to suppress deterioration of a pattern image projected on a substrate. The exposure apparatus comprises a nozzle member (70) having a supply opening (12) for supplying a ...


7
Hagihara Masahiko, Izumi Naoyuki, Tsuzaki Yasunori, Matsugi Takeshi, Nakajima Tadashi, Hatano Masakazu, Hara Hideaki: (Ja) 新規オレフィン誘導体, (En) Novel olefin derivative. Ube Industries, Santen Pharmaceutical, Hagihara Masahiko, Izumi Naoyuki, Tsuzaki Yasunori, Matsugi Takeshi, Nakajima Tadashi, Hatano Masakazu, Hara Hideaki, HIBI Norihiko, April 21, 2005: WO/2005/035501 (8 worldwide citation)

(EN) To prepare a novel olefin derivative useful as a medicine and to find out a new pharmacological activity of the derivative. The compound is represented by the general formula [I] and has excellent Rho-kinase inhibitory activity. In the formula, X is a benzene ring, cycloalkane ring, or monocycl ...


8
Kondo Makoto, Hara Hideaki: (Ja) ステージ装置及び露光装置、並びにデバイス製造方法, (En) Stage apparatus, exposure apparatus, and method of producing device. Nikon Corporation, Kondo Makoto, Hara Hideaki, TATEISHI Atsuji, December 2, 2004: WO/2004/105105 (5 worldwide citation)

(EN) A stage (WST) is guided by a guide surface (44a) of a first surface-plate (44) and minutely driven together with a moving-member unit in the X-axis direction, Y-axis direction, and rotating direction about the Z-axis. Further, the stage is driven integrally with a stationary-member unit in the ...


9
Hatano Masakazu, Nakajima Tadashi, Matsugi Takeshi, Hara Hideaki: (Ja) Rhoキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤, (En) Remedy for glaucoma comprising rho kinase inhibitor and &bgr;-blocker. Santen Pharmaceutical, Hatano Masakazu, Nakajima Tadashi, Matsugi Takeshi, Hara Hideaki, HIBI Norihiko, June 3, 2004: WO/2004/045644 (5 worldwide citation)

(EN) It is intended to establishing the usefulness as a remedy for glaucoma of a combination of an Rho kinase inhibitor, which has a novel function mechanism, with a &bgr;-blocker. By combining the Rho kinase inhibitor with the &bgr;-blocker, the effects of lowering ocular tension of these compounds ...


10
Nakajima Tadashi, Matsugi Takeshi, Hara Hideaki: (Ja) Rhoキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤, (En) Remedy for glaucoma comprising rho kinase inhibitor and prostaglandins. Santen Pharmaceutical, Nakajima Tadashi, Matsugi Takeshi, Hara Hideaki, HIBI Norihiko, March 11, 2004: WO/2004/019951 (5 worldwide citation)

(EN) It is intended to find out the usefulness as a remedy for glaucoma of a combination of an Rho kinase inhibitor with prostaglandins. By combining an Rho kinase inhibitor with prostaglandins, their effects of lowering ocular tension are complemented and/or enhanced each other. Concerning the admi ...